The New York Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-dark"]

Menu

Home
Wall Street Today
Economy
- Market Analysis
Newsletters and Research
Cryptocurrency
Business
Finance
Market Analysis
Money

Home
2024
May
Amgen scraps experimental weight loss pill, moves forward with injection

Amgen scraps experimental weight loss pill, moves forward with injection

Share

Read Time:6 Second

Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.

About Post Author

Happy

0 0 %

Sad

0 0 %

Excited

0 0 %

Sleepy

0 0 %

Angry

0 0 %

Surprise

0 0 %

0

0

Previous post Dave & Buster’s allowing arcade gambling raises ‘significant concerns,’ advocacy group says

Next post Monster Beverage lays out succession plans as co-CEO Rodney Sacks looks to step back

More Stories

Darden Restaurants earnings disappoint as Olive Garden, fine dining sales struggle

Olive Garden parent Darden Restaurants reported weaker-than-expected earnings and revenue for its fiscal first quarter.

September 19, 2024

We ranked the latest earnings reports from 30 portfolio stocks from great to ugly

Our companies' performances were reflective of the S&P 500 firms in aggregate.

September 14, 2024

Adobe stock slips on soft fourth-quarter revenue guidance

Adobe reported third-quarter results on Thursday that beat Wall Street expectations for sales and earnings.

September 13, 2024

Oracle bumps up fiscal 2026 revenue forecast, lifting stock 6%

Oracle is projecting higher revenue and capital expenditures as its cloud-computing arm grows.

September 12, 2024

These 5 portfolio stocks crushed the volatile market since our August Monthly Meeting

Investor concerns around the AI boom, coupled with the market's sensitivity to the Fed's next policy move, have caused Wall...

September 12, 2024

Goldman Sachs to post $400 million hit to third-quarter results as it unwinds consumer business

In late 2022, Goldman Sachs began to pivot away from its consumer operations, beginning a series of write-downs related to...

September 10, 2024

Post navigation

Previous post:Dave & Buster’s allowing arcade gambling raises ‘significant concerns,’ advocacy group says

Next post:Monster Beverage lays out succession plans as co-CEO Rodney Sacks looks to step back

Search for:

Recent Posts

CDs paying 5% are a dying breed. Here’s how to find high savings rates while you still can.
Stocks poised for first September gain in 5 years. Why more good times could lie ahead.
This mortgage hack could save you thousands a year — and it’s not a refinance
Diversify your 401(k) with these cheap investments that nobody else wants right now
Stock investors face a gut-wrenching 3 months ahead after record market run

Wall Street Today

Wall Street Today

Stocks to Watch

Other

Newsletters & Research

Policy & Regulation

Business

© 2022 The New York Entrepreneur. All Rights Reserved.